Roles of Notch Signaling in the Tumor Microenvironment

Int J Mol Sci. 2022 Jun 2;23(11):6241. doi: 10.3390/ijms23116241.

Abstract

The Notch signaling pathway is an architecturally simple signaling mechanism, well known for its role in cell fate regulation during organ development and in tissue homeostasis. In keeping with its importance for normal development, dysregulation of Notch signaling is increasingly associated with different types of tumors, and proteins in the Notch signaling pathway can act as oncogenes or tumor suppressors, depending on the cellular context and tumor type. In addition to a role as a driver of tumor initiation and progression in the tumor cells carrying oncogenic mutations, it is an emerging realization that Notch signaling also plays a role in non-mutated cells in the tumor microenvironment. In this review, we discuss how aberrant Notch signaling can affect three types of cells in the tumor stroma-cancer-associated fibroblasts, immune cells and vascular cells-and how this influences their interactions with the tumor cells. Insights into the roles of Notch in cells of the tumor environment and the impact on tumor-stroma interactions will lead to a deeper understanding of Notch signaling in cancer and inspire new strategies for Notch-based tumor therapy.

Keywords: Notch signaling; cancer; oncogene; tumor; tumor microenvironment; tumor suppressor gene.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Oncogenes
  • Receptors, Notch* / genetics
  • Receptors, Notch* / metabolism
  • Signal Transduction / physiology
  • Tumor Microenvironment

Substances

  • Receptors, Notch

Grants and funding

Work in the authors’ laboratories is supported by a grant from the Mayo-KI breast cancer research program (AD, UL). AD is also supported by the Randy Shaver Foundation and UL by the Swedish Cancer Society and the Swedish Research Council. RL-F is supported by CTSA Grant Number KL2 TR002379 from the National Center for Advancing Translational Science (NCATS), and the Mayo Clinic Breast Cancer SPORE grant P50 CA116201, Career Enhancement Program, from the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.